Pinned Tweet
Replying to @runendtoend
@runendtoend @UKRunChat pleased to have completed the 874miles #LEJOG9 this morning with an 11 mile run. Thanks to my family, friends and the dog for helping me along the way.
Amazing advance in pancreas perfusion to optimise quality for transplant. Will be interesting to follow progress and benefits for recipients.
📢 World’s first successful transplantation of a perfused human pancreas!
🎉 Congratulations to all involved at @OUHospitals and @UniofOxford!
👉 Full details: ouh.nhs.uk/news/articles/244…
Steven Patterson retweeted
NEW: "Staging prediabetes and type 2 diabetes: the time to start is now"
Viral N Shah and colleagues propose a model for type 2 diabetes that assumes gradual decline in β-cell function or mass over time in people at risk for developing type 2 diabetes.
thelancet.com/journals/landi…
Steven Patterson retweeted
Beyond the bacterial #microbiome a new focus on harnessing the gut non-bacterial microbial entities in the therapeutics and prevention of metabolic diseases sciencedirect.com/science/ar… @MolMetab #microbiota
Steven Patterson retweeted
Results in a mouse model indicate that clinically used type 2 diabetes treatments could be employed preventively to improve stroke outcome by exerting dual pharmacological action: weight loss and acute neuroprotection #T2D #DiabetesResearch link.springer.com/article/10… 🔓
Steven Patterson retweeted
BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
Steven Patterson retweeted
#1
In a paper just published online in Diabetes, we showed that homozygous loss-of-function mutations in the Glucagon receptor (GCGR) cause early-onset hepatic steatosis in people.
DOI: doi.org/10.2337/db25-0209
Steven Patterson retweeted
Fantastic news for the type 1 community! Thanks to clinical trial participants and researchers who have helped to make this happen.
Breaking news! 🎉 The first ever immunotherapy drug for type 1 diabetes, teplizumab, has been licensed for use in the UK.
Today, the UK’s medicine regulator (MHRA) confirmed teplizumab is safe and effective for people in the early, symptom-free stage 👉 orlo.uk/1eSqj
Steven Patterson retweeted
Today, @HannahVigh et al. unleash a freely available and searchable database of the human intestinal transcriptome - an atlas of the expression of 19,739 genes from 16 sites along the intestinal tract. Check out the landscape of your favourite gene here: rnaseq.gubra.dk
Steven Patterson retweeted
#Breaking: Today we announced updated data for our investigational islet cell therapy for the treatment of #Type1Diabetes. Learn more: news.vrtx.com/news-releases/…
Steven Patterson retweeted
It's Diabetes Week. Proud to be involved in diabetes research and education with many diabetes projects running at GCU and our work investigating diabetic wound repair diabetes.org.uk/support-us/d… @GCUReach @GCU_BIO @GCUSHLS
Steven Patterson retweeted
Biomedical science here @GCU_BIO @GCUstudents
Today is #BiomedicalScienceDay2025
We’re recognising the Biomedical Scientists, Clinical Scientists and lab staff #BehindEveryTest. Their expertise underpins 1.5 billion tests a year - vital to 85% of patient pathways.
They are #AtTheHeartOfHealthcare.
Steven Patterson retweeted
New Research: The evolution of the therapeutic concept ‘GIP receptor antagonism’ frontiersin.org/articles/10.… #FrontiersIn #Endocrinology
Steven Patterson retweeted
On World Health Day, we celebrate the dedication of our staff, researchers, graduates and current students, whose work continues to shape the future of healthcare. 🔬
👉 Learn more about @GCUSHLS on our website: gcu.ac.uk/aboutgcu/academics…
#WorldHealthDay #WeAreGCU
Steven Patterson retweeted
Pancreatic cancer, often linked to smoking, obesity and diabetes, is predicted to become the 2nd leading cause of cancer-related death by 2030.
A new Seminar discusses the need for novel therapies & future directions for research: hubs.li/Q03fW9vm0
Steven Patterson retweeted
📣 NEWS: We’re excited to announce that the Scottish Intercollegiate Guidelines Network (SIGN) has published new clinical guidelines on the prevention and remission of #type2diabetes in Scotland!
But what does this mean? 👇
Steven Patterson retweeted
Here the authors associate western dietary pattern metabolite scores and neurodevelopmental outcomes, including #ADHD #Autism that are consistently significant in early–mid-pregnancy #diet #pregnancy @NatMetabolism nature.com/articles/s42255-0…
Nice to be back @DiabetesUK at the SEC in Glasgow to hear about the latest advances in Diabetes, network and for our @GCU_BIO PhD student Fatimoh to share her current research.
Steven Patterson retweeted
Excited to share our publication in @iScience_CP Islet single-cell transcriptomic profiling during obesity-induced beta cell expansion in female mice #IMM @UTHealthHouston @bcmhouston 🧵 cell.com/iscience/fulltext/S…








































